Cancer-associated fibroblasts, a parameter of the tumor microenvironment, overcomes carcinoma-associated parameters in the prognosis of patients with mobile tongue cancer

Oral Oncology

Volumn 47, Issue 1, 2011, Pages 33-38

  Bello, Ibrahim O ^a   Vered, Marilena ^b,c   Dayan, Dan ^b   Dobriyan, Alex ^c   Yahalom, Ran ^c   Alanen, Kalle ^d   Nieminen, Pentti ^a   Kantola, Saara ^a,e   Läärä, Esa ^a   Salo, Tuula ^a,e  

^a UNIVERSITY OF OULU   (Finland)

^b TEL AVIV UNIVERSITY   (Israel)

^c SHEBA MEDICAL CENTER   (Israel)

^d UNIVERSITY OF TURKU   (Finland)

^e OULU UNIVERSITY HOSPITAL   (Finland)

Author keywords

Cancer associated fibroblasts; Disease specific mortality; DNA content; Ki 67; Maspin; Oral cancer; Ploidy; Prognosis; Stromal myofibroblasts; Tongue cancer

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; DNA; KI 67 ANTIGEN; MASPIN;

ADULT; AGED; ARTICLE; CANCER ASSOCIATED FIBROBLAST; CELL DENSITY; CELL TYPE; DISEASE COURSE; DNA CONTENT; FEMALE; FIBROBLAST; HUMAN; HUMAN CELL; HUMAN TISSUE; LABELING INDEX; MAJOR CLINICAL STUDY; MALE; MOBILE TONGUE SQUAMOUS CELL CARCINOMA; MORTALITY; PRIORITY JOURNAL; PROGNOSIS; TONGUE CANCER; TUMOR MICROENVIRONMENT;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; FEMALE; FIBROBLASTS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; PROGNOSIS; TONGUE NEOPLASMS; TUMOR MARKERS, BIOLOGICAL; TUMOR MICROENVIRONMENT; YOUNG ADULT;

EID: 79551572428     PISSN: 13688375     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.oraloncology.2010.10.013     Document Type: Article

References (41)

1. M.P. Rethman, W. Carpenter, E.E. Cohen, J. Epstein, C.A. Evans, and C.M. Flaitz Evidence-based clinical recommendations regarding screening for oral squamous cell carcinoma JADA 141 5 2010 509 520
2. A. Jemal, R. Siegal, J. Xu, and E. Ward Cancer statistics Ca Cancer J Clin 60 5 2010 277 300
3. I.O. Bello, Y. Soini, and T. Salo Prognostic evaluation of oral tongue cancer: means, markers and perspectives (II) Oral Oncol 46 9 2010 636 643
4. K. Yoshida, K. Kashima, S. Suenaga, N. Nomi, J. Shuto, and M. Suzuki Immunohistochemical detection of cervical lymph node micrometastases from T2N0 tongue cancer Acta Otolaryngol 125 6 2005 654 658
5. F.C. Rodrigues-Lisoni, P. Peitl, A. Vidotto, G.M. Polachini, J.V. Maniglia, and J. Carmona-Raphe Genomics and proteomics approaches to the study of cancer-stroma interactions BMC Med Genom 3 2010 14
6. R. Kalluri, and M. Zeisberg Fibroblasts in cancer Nat Rev Cancer 6 5 2006 392 401
7. M. Vered, I. Allon, A. Buchner, and D. Dayan Stromal myofibroblasts and malignant transformation in a 4NQO rat tongue carcinogenesis model Oral Oncol 43 10 2007 999 1006
8. M. Vered, I. Allon, A. Buchner, and D. Dayan Stromal myofibroblasts accompany modifications in the epithelial phenotype of tongue dysplastic and malignant lesions Cancer Microenviron 2 1 2009 49 57
9. M. Vered, A. Dobriyan, D. Dayan, R. Yahalom, Y.P. Talmi, and L. Bedrin Tumor-host histopathologic variables, stromal myofibroblasts and risk score, are significantly associated with recurrent disease in tongue cancer Cancer Sci 101 1 2010 274 280
10. M.G. Kellerman, L.M. Sobral, S.D. da Silva, K.G. Zecchin, E. Graner, and M.A. Lopes Myofibroblasts in the stroma of oral squamous cell carcinoma are associated with poor prognosis Histopathology 51 6 2007 849 853
11. M. Vered, D. Dayan, R. Yahalom, A. Dobriyan, I. Barshack, and I.O. Bello Cancer-associated fibroblasts and epithelial-mesenchymal transition in metastatic oral tongue squamous cell carcinoma Int J Cancer 127 6 2010 1356 1362
12. Z. Khalkhali-Ellis Maspin: the new frontier Clin Cancer Res 12 24 2006 7279 7282
13. N.I. Affara, and L.M. Coussens IKKα at the crossroads of inflammation and metastasis Cell 129 1 2007 25 26
14. A. Mantovani, P. Allavena, A. Sica, and F. Balkwill Cancer-related inflammation Nature 454 7203 2008 436 444
15. R. Yasumatsu, T. Nakashima, N. Hirakawa, Y. Kumamoto, Y. Kuratomi, and K. Tomita Maspin expression in stage I and II oral tongue squamous cell carcinoma Head Neck 23 11 2001 962 966
16. J.H. Cho, H.S. Kim, C.S. Park, J.K. Kim, K.Y. Jung, and B.K. Shin Maspin expression in early oral tongue cancer and its relation to expression of mutant-type p53 and vascular endothelial growth factor (VEGF) Oral Oncol 43 3 2007 272 277
17. I.O. Bello, K. Alanen, P.J. Slootweg, and T. Salo Alpha-smooth muscle actin within epithelial islands is predictive of ameloblastic carcinoma Oral Oncol 45 9 2009 760 765
18. J.M. Satagopan, L. Ben-Porat, M. Berwick, M. Robson, D. Kutler, and A.D. Auerbach A note on competing risks in survival data analysis Br J Cancer 91 7 2004 1229 1235
19. R Development Core Team. R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria 2010. Available at http://www.R-project.org (accessed 09.11.2010).
20. D. Liao, Y. Luo, D. Markowitz, R. Xiang, and R.A. Reisfeld Cancer associated fibroblasts promote tumor growth and metastasis by modulating the tumor immune microenvironment in a 4T1 murine breast cancer model PLoS ONE 4 11 2009 e7965
21. E. Giannoni, F. Bianchini, L. Masieri, S. Serni, E. Torre, and L. Calorini Reciprocal activation of prostate cancer cells and cancer-associated fibroblasts stimulates epithelial-mesenchymal transition and cancer stemness Cancer Res 70 17 2010 OF1 OF12
22. K. Zhi, X. Shen, H. Zhang, and J. Bi Cancer-associated fibroblasts are positively correlated with metastatic potential of human gastric cancers J Exp Clin Cancer Res 29 2010 66 10.1186/1756-9966-29-6
23. T. Tsujino, I. Seshimo, H. Yamamoto, C.Y. Ngan, K. Ezumi, and I. Takemasa Stromal myofibroblasts predict disease recurrence for colorectal cancer Clin Cancer Res 13 7 2007 2082 2090
24. V. Tzelepi, P. Grivas, Z. Kefalopoulou, H. Kalofonos, J.N. Varakis, and M. Melachrinou Estrogen signaling in colorectal carcinoma microenvironment: expression of ERbeta1, AIB-1, and TIF-2 is upregulated in cancer-associated myofibroblasts and correlates with disease progression Virchows Arch 454 4 2009 389 399
25. P. Surowiak, D. Murawa, V. Materna, A. Maciejczyk, M. Pudelko, and S. Ciesla Occurrence of stromal myofibroblasts in the invasive ductal breast cancer tissue is an unfavourable prognostic factor Anticancer Res 27 4C 2007 2917 2924
26. C. Yazhou, S. Wenlv, Z. Weidong, and W. Licun Clinicopathological significance of stromal myofibroblasts in invasive ductal carcinoma of the breast Tumour Biol 25 5-6 2004 290 295
27. S. Josson, Y. Matsuoka, L.W. Chung, H.E. Zhau, and R. Wang Tumor-stroma co-evolution in prostate cancer progression and metastasis Semin Cell Dev Biol 21 1 2010 26 32
28. C. Gaggioli, S. Hooper, C. Hidalgo-Carcedo, R. Grosse, J.F. Marshall, and K. Harrington Fibroblast-led collective invasion of carcinoma cells with differing roles for RhoGTPases in leading and following cells Nat Cell Biol 9 12 2007 1392 1400
29. N. Erez, M. Truitt, P. Olson, and D. Hanahan Cancer-associated fibroblasts are activated in incipient neoplasia to orchestrate tumor-promoting inflammation in an NF-κB-dependent manner Cancer Cell 17 2 2010 135 147
30. Z. Cai, Y. Zhou, T. Lei, J.F. Chiu, and Q.Y. He Mammary serine protease inhibitor inhibits epithelial growth factor induced epithelial-mesenchymal transition of esophageal carcinoma cells Cancer 115 1 2009 36 48
31. J. Lockett, S. Yin, X. Li, Y. Meng, and S. Sheng Tumor suppressive maspin and epithelial homeostasis J Cell Biochem 97 4 2006 651 660
32. H. Ye, T. Yu, S. Temam, B.L. Ziober, J. Wang, and J.L. Schwartz Transcriptomic dissection of tongue squamous cell carcinoma BMC Genom 9 2008 69 10.1186/1471-2164-9-6
33. S.D. Silva, D.E. Perez, F.A. Alves, I.N. Nishimoto, C.A. Pinto, and L.P. Kowalski ErbB2 and fatty acid synthase (FAS) expression in 102 squamous cell carcinomas of the tongue: correlation with clinical outcomes Oral Oncol 44 5 2008 484 490
34. R.J. Bova, D.I. Quinn, J.S. Nankervis, I.E. Cole, B.F. Sheridan, and M.J. Jensen Cyclin D1 and p16INK4A expression predict reduced survival in carcinoma of the anterior tongue Clin Cancer Res 5 10 1999 2810 2819
35. M.A. Gonzalez-Moles, I. Ruiz-Avila, J.A. Gil-Montoya, F. Esteban, and M. Bravo Analysis of Ki-67 expression in oral squamous cell carcinoma: why Ki-67 is not a prognostic indicator Oral Oncol 46 7 2010 525 530
36. D. Wangsa, M. Ryott, E. Avall-Lundqvist, F. Petersson, G. Elmberger, and J. Luo Ki-67 expression predicts locoregional recurrence in stage I oral tongue carcinoma Br J Cancer 99 7 2008 1121 1128
37. R. Saiz-Bustillo, G. Corchero-Martin, B. Garcia-Montesinos-Perea, T. Gonzalez-Teran, and S. Sanchez-Santolino Oral squamous cell carcinoma. Cytometric parameters of prognostic interest Med Oral Patol Oral Cir Bucal 10 5 2005 462 467
38. J. Hemmer, E. Nagel, and K. Kraft DNA aneuploidy by flow cytometry is an independent prognostic factor in squamous cell carcinoma of the oral cavity Anticancer Res 19 2B 1999 1419 1422
39. C. Melchiorri, L. Cattini, E. Lalli, A. Campobassi, C. Marchetti, and A. Facchini DNA ploidy analysis of squamous cell carcinomas of the oral and maxillofacial region: clinical and pathologic correlations Oral Surg Oral Med Oral Pathol Oral Radiol Endod 82 3 1996 308 314
40. G. Baretton, X. Li, C. Stoll, E. Fischer-Brandies, M. Schmidt, and U. Lohrs Prognostic significance of DNA ploidy in oral squamous cell carcinomas. A retrospective flow and image cytometric study with comparison of DNA ploidy in excisional biopsy specimens and resection specimens, primary, tumors, and lymph node metastases Oral Surg Oral Med Oral Pathol Oral Radiol Endod 79 1 1995 68 76
41. M. Pentenero, M. Maffei, P. Scaruffi, A. Donadini, E. Di Nallo, and D. Malacarne Genetically altered fields in oral precancer: DNA-FCM and a-CGH Oral Dis 16 6 2010 520 [abstract]